Literature DB >> 6263974

Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.

J Seeley, E Svedmyr, O Weiland, G Klein, E Moller, E Eriksson, K Andersson, L van der Waal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6263974

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  16 in total

1.  In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.

Authors:  G Strang; A B Rickinson
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

2.  Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.

Authors:  M Yanagisawa; M Kato; K Ikeno; T Kobayashi; Y Miyagawa; A Komiyama; T Akabane
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

Review 3.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

4.  T lymphocytes in infectious mononucleosis. I. T cell death in vitro.

Authors:  D J Moss; C J Bishop; S R Burrows; J M Ryan
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

Review 5.  The role of the human major histocompatibility complex in cytotoxic T-cell responses to virus-infected cells.

Authors:  W E Biddison
Journal:  J Clin Immunol       Date:  1982-01       Impact factor: 8.317

Review 6.  Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.

Authors:  E Klein; M G Masucci
Journal:  Springer Semin Immunopathol       Date:  1982

Review 7.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

8.  Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.

Authors:  F Wang; R M Blaese; K C Zoon; G Tosato
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

9.  Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.

Authors:  P C Patel; G Dorval; J Menezes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.

Authors:  H Plotnicky; J L Touraine
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.